Patients self-administered a hospital-equivalent diuretic treatment resulting in a reduction of approximately 4 inpatient days per episode, according to study published in the Journal of the American College of Cardiology. BURLINGTON, Mass., Oct. 14, 2026 /PRNewswire/ — SQ Innovation…
Tag: SQ Innovation
Interim Real-World Results Show At-Home Subcutaneous Furosemide Can Effectively Treat Worsening Heart Failure in Patients at Imminent Risk for Hospital Admission
Gator SCALES-WHF, an investigator-sponsored study at the University of Florida, shows effective decongestion of patients at imminent risk for hospital admission with minimal user, device or safety issues; 30-day admission for treatment failure or insufficient response was rare….
SQ Innovation Announces FDA Approval of Lasix® ONYU for Treatment of Edema in Heart Failure
Second-generation delivery device offers cost-effective alternative to hospital care benefiting patients, providers and payors Worsening heart failure is among the top three indications for hospitalizations in the elderly BURLINGTON, Mass., Oct. 8, 2025 /PRNewswire/ — SQ Innovation, Inc….



